Gennova sees uptick in its Omicron-specific COVID booster – ET HealthWorld | Pharma
New Delhi: Pune-based biotech firm Gennova Biopharmaceuticals has witnessed a demand uptick for its Omicron-specific Covid-19 vaccine, with the recent…
Fast News Hear
New Delhi: Pune-based biotech firm Gennova Biopharmaceuticals has witnessed a demand uptick for its Omicron-specific Covid-19 vaccine, with the recent…
Duesseldorf: A German court on Thursday suspended a patent trial against BioNTech over the use of mRNA technology in the…
Bengaluru: Moderna said on Tuesday it will cut production of mRNA drug substance for its COVID-19 vaccine at Lonza‘s facility…
New Delhi: In a recent announcement, CureVac, working in partnership with GSK, disclosed the advancement of its modified mRNA seasonal…
Shanghai: China‘s CanSino Biologics , which recently announced a contract manufacturing deal to support AstraZenca‘s messenger RNA (mRNA) technology vaccine…
London: With the rise of mRNA-based treatments, the field of oncology is about to go through a big change. The…
Shangai: China‘s Stemirna Therapeutics said on Wednesday it had suspended work at a factory it had planned to use to…
Beijing: China‘s CSPC Pharmaceutical Group Limited said on Wednesday its messenger RNA (mRNA) COVID-19 vaccine had received emergency use authorisation…
Nanded: Telangana Chief Minister K Chandrashekar Rao has alleged that the Central government did everything possible to “forcefully” prevent import…
Bengaluru: BioNTech SE has signed a deal with the UK government to enroll up to 10,000 patients in clinical trials…